首页> 外文期刊>The Open Pain Journal >Use of Ketamine in Ameliorating Opioid Withdrawal Symptoms During an Induction Phase of Buprenorphine
【24h】

Use of Ketamine in Ameliorating Opioid Withdrawal Symptoms During an Induction Phase of Buprenorphine

机译:氯胺酮在丁丙诺啡诱导阶段缓解阿片类药物戒断症状中的应用

获取原文
       

摘要

Ketamine can be used in the treatment of opioid withdrawal symptoms. Here are two case discussions oftreatment of withdrawal symptoms in opioid dependent patients undergoing detoxification. Our case reports endorse thehypothesis that N-methyl D-aspartate (NMDA) antagonists may selectively inhibit the expression of opiate withdrawal.The use of intravenous ketamine can be considered as a bridge to successful initiation of buprenorphine to wean thepatient off from high opioid doses while providing adequate analgesia during the transition period.
机译:氯胺酮可用于治疗阿片类药物戒断症状。这是治疗排毒的阿片类药物依赖患者戒断症状的两个案例讨论。我们的案例报告支持N-甲基D-天冬氨酸(NMDA)拮抗剂可能选择性抑制阿片戒断的表达的假说。静脉内注射氯胺酮可被视为成功启动丁丙诺啡以使患者摆脱高剂量阿片类药物的桥梁在过渡期间提供足够的镇痛作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号